Actively Recruiting
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Led by Sichuan Provincial People's Hospital · Updated on 2024-07-09
300
Participants Needed
1
Research Sites
14 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those with bacterial sepsis. Conducted at Sichuan Provincial People's Hospital, the study will retrospectively analyze data from ICU patients admitted between July 2021 and December 2023. The primary objective is to identify reliable biomarkers and diagnostic methods to improve patient outcomes through personalized diagnostic and therapeutic strategies.
CONDITIONS
Official Title
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with sepsis according to Sepsis 3.0 criteria
- Confirmed bacterial sepsis by positive bacterial cultures
- Confirmed viral sepsis with COVID-19 diagnosed via RT-PCR
- Aged 18 years or older
- Admitted to the ICU during the study period
You will not qualify if you...
- Mixed bacterial and viral infections
- Sepsis not meeting Sepsis 3.0 criteria
- Received immunomodulatory therapies other than standard treatments
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610091
Actively Recruiting
Research Team
L
Lin Chen, doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here